369 related articles for article (PubMed ID: 8375246)
1. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
2. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
[TBL] [Abstract][Full Text] [Related]
3. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
[TBL] [Abstract][Full Text] [Related]
4. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
5. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
7. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
8. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.
Kelley DE; Mandarino LJ
J Clin Invest; 1990 Dec; 86(6):1999-2007. PubMed ID: 2123890
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
[TBL] [Abstract][Full Text] [Related]
11. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
Luzi L; Petrides AS; De Fronzo RA
Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
[TBL] [Abstract][Full Text] [Related]
12. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
13. Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans.
Kelley DE; Reilly JP; Veneman T; Mandarino LJ
Am J Physiol; 1990 Jun; 258(6 Pt 1):E923-9. PubMed ID: 2113769
[TBL] [Abstract][Full Text] [Related]
14. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
15. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.
Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR
J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341
[TBL] [Abstract][Full Text] [Related]
16. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
[TBL] [Abstract][Full Text] [Related]
17. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.
Laakso M; Edelman SV; Brechtel G; Baron AD
Diabetes; 1992 Sep; 41(9):1076-83. PubMed ID: 1499861
[TBL] [Abstract][Full Text] [Related]
18. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
[TBL] [Abstract][Full Text] [Related]
19. Alterations in glucose metabolism in the elderly patient with diabetes.
Meneilly GS; Dawson K; Tessier D
Diabetes Care; 1993 Sep; 16(9):1241-8. PubMed ID: 8404427
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1993 Dec; 265(6 Pt 1):E898-905. PubMed ID: 8279545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
